Literature DB >> 23871450

CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging study.

Christian Clemm von Hohenberg1, Marlene C Wigand, Marek Kubicki, Gregor Leicht, Ina Giegling, Susanne Karch, Annette M Hartmann, Bettina Konte, Marion Friedl, Thomas Ballinger, Ryan Eckbo, Sylvain Bouix, Lorenz Jäger, Martha E Shenton, Dan Rujescu, Christoph Mulert.   

Abstract

CNTNAP2 is a gene on chromosome 7 that has shown associations with autism and schizophrenia, and there is evidence that it plays an important role for neuronal synchronization and brain connectivity. In this study, we assessed the relationship between Diffusion Tensor Imaging (DTI), a putative marker of anatomical brain connectivity, and multiple single nucleotide polymorphisms (SNPs) spread out over this large gene. 81 healthy controls and 44 patients with schizophrenia (all Caucasian) underwent DTI and genotyping of 31 SNPs within CNTNAP2. We employed Tract-based Spatial Statistics (TBSS) for inter-subject brain registration and computed average diffusivity values for six major white matter tracts. Analyses of Covariance (ANCOVAs) were computed to test for possible associations with genotypes. The strongest association, which survived rigorous Bonferroni correction, was between rs2710126 genotype and Fractional Anisotropy (FA) in the uncinate fasciculus (p = .00003). This anatomical location is particularly interesting given the enriched fronto-temporal expression of CNTNAP2 in the developing brain. For this SNP, no phenotype association has been reported before. There were several further genotype-DTI associations that were nominally significant but did not survive Bonferroni correction, including an association between axial diffusivity in the dorsal cingulum bundle and a region in intron 13 (represented by rs2710102, rs759178, rs2538991), which has previously been reported to be associated with anterior-posterior functional connectivity. We present new evidence about the effects of CNTNAP2 on brain connectivity, whose disruption has been hypothesized to be central to schizophrenia pathophysiology.
© 2013 Published by Elsevier Ltd.

Entities:  

Keywords:  Autism; Caspr2; Endophenotype; Genetics; Magnetic resonance imaging; Schizophrenia

Mesh:

Substances:

Year:  2013        PMID: 23871450      PMCID: PMC3780783          DOI: 10.1016/j.jpsychires.2013.07.002

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  61 in total

1.  Nonrigid registration using free-form deformations: application to breast MR images.

Authors:  D Rueckert; L I Sonoda; C Hayes; D L Hill; M O Leach; D J Hawkes
Journal:  IEEE Trans Med Imaging       Date:  1999-08       Impact factor: 10.048

2.  Altered structural brain connectivity in healthy carriers of the autism risk gene, CNTNAP2.

Authors:  Emily L Dennis; Neda Jahanshad; Jeffrey D Rudie; Jesse A Brown; Kori Johnson; Katie L McMahon; Greig I de Zubicaray; Grant Montgomery; Nicholas G Martin; Margaret J Wright; Susan Y Bookheimer; Mirella Dapretto; Arthur W Toga; Paul M Thompson
Journal:  Brain Connect       Date:  2011

3.  Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels.

Authors:  S Poliak; L Gollan; R Martinez; A Custer; S Einheber; J L Salzer; J S Trimmer; P Shrager; E Peles
Journal:  Neuron       Date:  1999-12       Impact factor: 17.173

4.  Investigating gradients of gene expression involved in early human cortical development.

Authors:  Bui K Ip; Ilka Wappler; Heiko Peters; Susan Lindsay; Gavin J Clowry; Nadhim Bayatti
Journal:  J Anat       Date:  2010-10       Impact factor: 2.610

5.  Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.

Authors:  Kevin A Strauss; Erik G Puffenberger; Matthew J Huentelman; Steven Gottlieb; Seth E Dobrin; Jennifer M Parod; Dietrich A Stephan; D Holmes Morton
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

6.  Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.

Authors:  C O'Dushlaine; E Kenny; E Heron; G Donohoe; M Gill; D Morris; A Corvin
Journal:  Mol Psychiatry       Date:  2010-02-16       Impact factor: 15.992

7.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

8.  Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis.

Authors:  S L Eastwood; P J Harrison
Journal:  Mol Psychiatry       Date:  2003-09       Impact factor: 15.992

Review 9.  Schizophrenia: a disconnection syndrome?

Authors:  K J Friston; C D Frith
Journal:  Clin Neurosci       Date:  1995

10.  CNTNAP2 variants affect early language development in the general population.

Authors:  A J O Whitehouse; D V M Bishop; Q W Ang; C E Pennell; S E Fisher
Journal:  Genes Brain Behav       Date:  2011-03-01       Impact factor: 3.449

View more
  18 in total

Review 1.  Applying imaging genetics to ADHD: the promises and the challenges.

Authors:  Zhaomin Wu; Li Yang; Yufeng Wang
Journal:  Mol Neurobiol       Date:  2014-04-01       Impact factor: 5.590

2.  Processing speed impairment in schizophrenia is mediated by white matter integrity.

Authors:  H Karbasforoushan; B Duffy; J U Blackford; N D Woodward
Journal:  Psychol Med       Date:  2014-05-15       Impact factor: 7.723

Review 3.  Neural signatures of autism spectrum disorders: insights into brain network dynamics.

Authors:  Leanna M Hernandez; Jeffrey D Rudie; Shulamite A Green; Susan Bookheimer; Mirella Dapretto
Journal:  Neuropsychopharmacology       Date:  2014-07-11       Impact factor: 7.853

4.  Altered white-matter integrity in unaffected siblings of probands with autism spectrum disorders.

Authors:  Yi-Ling Chien; Yu-Jen Chen; Yung-Chin Hsu; Wen-Yih Isaac Tseng; Susan Shur-Fen Gau
Journal:  Hum Brain Mapp       Date:  2017-09-20       Impact factor: 5.038

5.  White matter alterations in adult with autism spectrum disorder evaluated using diffusion kurtosis imaging.

Authors:  Aki Hattori; Koji Kamagata; Eiji Kirino; Christina Andica; Shoji Tanaka; Akifumi Hagiwara; Shohei Fujita; Tomoko Maekawa; Ryusuke Irie; Kanako K Kumamaru; Michimasa Suzuki; Akihiko Wada; Masaaki Hori; Shigeki Aoki
Journal:  Neuroradiology       Date:  2019-06-18       Impact factor: 2.804

6.  White matter abnormalities in schizophrenia and schizotypal personality disorder.

Authors:  Marc S Lener; Edmund Wong; Cheuk Y Tang; William Byne; Kim E Goldstein; Nicholas J Blair; M Mehmet Haznedar; Antonia S New; Eran Chemerinski; King-Wai Chu; Liza S Rimsky; Larry J Siever; Harold W Koenigsberg; Erin A Hazlett
Journal:  Schizophr Bull       Date:  2014-06-23       Impact factor: 9.306

Review 7.  Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia.

Authors:  Aristotle N Voineskos
Journal:  Schizophr Res       Date:  2014-06-02       Impact factor: 4.939

8.  Altered lateralization of dorsal language tracts in 6-week-old infants at risk for autism.

Authors:  Janelle Liu; Tawny Tsang; Lisa Jackson; Carolyn Ponting; Shafali S Jeste; Susan Y Bookheimer; Mirella Dapretto
Journal:  Dev Sci       Date:  2018-11-28

9.  Auditory verbal hallucinations and the interhemispheric auditory pathway in chronic schizophrenia.

Authors:  Marlene Wigand; Marek Kubicki; Christian Clemm von Hohenberg; Gregor Leicht; Susanne Karch; Ryan Eckbo; Paula E Pelavin; Kathryn Hawley; Dan Rujescu; Sylvain Bouix; Martha E Shenton; Christoph Mulert
Journal:  World J Biol Psychiatry       Date:  2014-09-16       Impact factor: 4.132

10.  Association of GRM3 polymorphism with white matter integrity in schizophrenia.

Authors:  Joanna Mounce; Li Luo; Arvind Caprihan; Jingyu Liu; Nora I Perrone-Bizzozero; Vince D Calhoun
Journal:  Schizophr Res       Date:  2014-03-26       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.